TAK-411 clinical trials

A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

This study is testing a new medicine, TAK-411, for adults with CIDP, a condition where the body's immune system attacks its nerves. We want to see if TAK-411 can help reduce inflammation and improve muscle strength and sensation over nearly a year.